BioRem Inc. (TSXV:BRM)

BioRem Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30	49	16	14	14	21
Market Cap Growth	54.38%	213.21%	15.10%	-2.10%	-33.28%	35.00%
Enterprise Value	24	46	17	15	5	12
Last Close Price	1.92	3.05	1.00	0.88	0.90	0.54
PE Ratio	14.30	16.15	7.20	8.46	10.74	9.99
PS Ratio	0.83	1.31	0.62	0.47	0.57	0.86
PB Ratio	2.82	4.63	2.34	3.02	7.09	1.54
P/TBV Ratio	2.82	4.63	2.34	3.02	7.09	1.54
P/FCF Ratio	7.35	14.84	-	10.98	3.76	6.96
P/OCF Ratio	7.17	13.34	32.03	9.44	3.68	6.24
EV/Sales Ratio	0.66	1.22	0.67	0.52	0.19	0.47
EV/EBITDA Ratio	5.31	9.76	5.14	5.01	1.90	4.83
EV/EBIT Ratio	6.02	10.38	5.46	5.21	2.02	5.08
EV/FCF Ratio	5.83	13.77	-	12.09	1.27	3.84
Debt / Equity Ratio	0.32	0.34	0.62	1.05	2.88	0.06
Debt / EBITDA Ratio	0.75	0.73	1.21	1.47	2.12	0.32
Debt / FCF Ratio	0.82	1.07	-	3.82	1.53	0.28
Asset Turnover	1.44	1.42	1.12	1.45	1.19	1.23
Inventory Turnover	11.95	14.38	20.28	22.46	19.76	15.57
Quick Ratio	1.29	1.34	1.18	1.24	1.10	2.11
Current Ratio	1.65	1.63	1.41	1.38	1.22	2.34
Return on Equity (ROE)	30.30%	35.10%	38.78%	49.75%	16.75%	16.55%
Return on Assets (ROA)	9.88%	10.44%	8.61%	9.02%	7.09%	7.15%
Return on Capital (ROIC)	19.49%	21.89%	19.12%	21.30%	13.27%	10.82%
Return on Capital Employed (ROCE)	29.70%	32.60%	30.30%	36.90%	39.30%	16.00%
Earnings Yield	9.08%	6.19%	13.88%	11.83%	9.31%	10.01%
FCF Yield	13.61%	6.74%	-0.40%	9.10%	26.60%	14.37%
Buyback Yield / Dilution	-1.38%	-0.59%	10.72%	53.08%	5.32%	-2.20%

Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.